Current report No. 8/2023 – Notification about a transaction on subscription warrants of Celon Pharma S.A.

April 28, 2023, 02:40 PM
Legal basis: Article 19 section 3 of the Market Abuse Regulation (MAR) – information on transactions conducted by persons discharging managerial responsibilities. 

Content of the report:

The Management Board of Celon Pharma S.A. (the “Company”) hereby informs that on April 28, 2023, it received a notification from a person discharging managerial responsibilities in the Company – Ms Dorota Zwolińska – on her acquisition (under the Incentive Program for members of the Management Board) of A-series registered subscription warrants entitling her to acquire C-series shares of the Company issued under a conditional share capital increase. The allocation of the A-series subscription warrants took place on April 25, 2023.

The Company attaches the notification in question.